Ana Maria Moro
Papers
2
Total Citations
26
H-Index
2
About
Dr. Ana Maria Moro is a distinguished biotechnologist whose research centers on the development and optimization of therapeutic monoclonal antibodies, with a particular focus on expression systems in Chinese hamster ovary (CHO) cells. Her work has significantly advanced the field of biopharmaceutical production, especially in the creation of biosimilar antibodies. Dr. Moro's most cited study, "Comparison of Humanized IgG and FvFc Anti-CD3 Monoclonal Antibodies Expressed in CHO Cells" (2010, 21 citations), provided critical insights into antibody engineering and expression efficiency, establishing a foundation for subsequent innovations. Her later work, "A new CHO-derived cell line expressing anti-TNFα monoclonal antibody with biosimilar potential" (2018, 5 citations), demonstrates her ongoing commitment to developing cost-effective therapeutic alternatives for inflammatory diseases. Through these contributions, Dr. Moro has not only advanced our understanding of recombinant protein expression but also paved the way for more accessible biologic treatments, making her a key figure in the intersection of cellular engineering and clinical therapeutics.
Research Focus
Key Achievements
Top Papers
- 1
- 2